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Abstract
Glaucoma disease progression, as measured by visual field (VF) data, is often
defined by periods of relative stability followed by an abrupt decrease in visual
ability at some point in time. Determining the transition point of the disease
trajectory to a more severe state is important clinically for disease manage-
ment and for avoiding irreversible vision loss. Based on this, we present a
unified statistical modeling framework that permits prediction of the tim-
ing and spatial location of future vision loss and informs clinical decisions
regarding disease progression. The developed method incorporates anatomi-
cal information to create a biologically plausible data-generating model. We
accomplish this by introducing a spatially varying coefficients model that in-
cludes spatially varying change points to detect structural shifts in both the
mean and variance process of VF data across both space and time. The VF
location-specific change point represents the underlying, and potentially cen-
sored, timing of true change in disease trajectory while a multivariate spatial
boundary detection structure is introduced that accounts for the complex
spatial connectivity of the VF and optic disc. We show that our method
improves estimation and prediction of multiple aspects of disease manage-
ment in comparison to existing methods through simulation and real data
application. The R package spCP implements the new methodology.
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1. Introduction
Glaucoma is an optic neuropathy that is the leading cause of irreversible
vision loss worldwide (Tham et al., 2014). Once a patient is diagnosed, they
are at risk of disease progression and are closely monitored by clinicians
who must balance the potential of further irreversible deterioration of vision
with the costs (financial and physical) of medical and surgical interventions.
The visual ability of a glaucoma patient is most often quantified through
visual field (VF) examinations, a psychophysical procedure that assesses a
patient’s field of vision. VF tests are performed during clinical visits over
time, producing a time series of spatial referenced data, and the results are
monitored for signs of glaucomatous VF progression. Determining if the
disease is progressing remains one of the most challenging aspects of glaucoma
management, as it is difficult to differentiate true progression from testing
variability (Vianna and Chauhan, 2015).
Although VF testing is a common technique for assessing glaucoma pro-
gression, there is currently no reference standard approach for converting
its output into a treatment decision. The majority of past studies can be
grouped into two categories, global- and trend-based analyses. Global meth-
ods provide a single summary of the VF data at each visit, thus aggregating
and potentially ignoring key information across VF locations (Heijl et al.,
1987). These global summaries are then monitored over time to investigate
the potential of disease progression. Trend methods analyze the individual
time series of sensitivities at each VF location (Fitzke et al., 1996). These
methods often resort to separately modeling the sensitivities over time assum-
ing a linear relationship, often through use of simple linear regression (Katz
et al., 1997). The inference obtained from these methods can be a poor di-
agnostic of progression or have inferior prediction accuracy, in comparison
to non-linear models (Jampel et al., 2011), and suffers from low power due
to ignoring the spatial nature of VF data or aggregating over space (Vianna
and Chauhan, 2015).
In this paper, we develop an innovative method that utilizes spatially
varying change points (CPs) to accurately model the VF sensitivities over
time. Patients diagnosed with glaucoma are often monitored for years with
only slow changes in visual functionality (Heijl et al., 2002). It is not until
disease progression that notable vision loss occurs, and the deterioration is
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often swift (Jay and Murdoch, 1993). This disease course inspires a model-
ing framework that can identify a point of functional change in the course
of follow-up. By utilizing the CP framework, the concept of disease progres-
sion becomes intrinsically parameterized into the model. Not only does the
specification increase flexibility in modeling the trajectory of the VF time
series by relaxing the linearity assumption, but the CP represents the point
of functional change and can be used to make inferential statements about
disease progression. This framework is particularly rich, however, because
in addition to there being a functional change in the VF sensitivities upon
the start of progression, there is also an increase in testing variance in areas
of decreased sensitivity. This inverse variance relationship upon progression
is well known in the glaucoma literature, although is often ignored in model
development (Russell et al., 2012). We use a CP to segment the variance
into a stable process that has the flexibility to increase after the point of pro-
gression. Finally, we focus on the joint modeling of all available VF data for
a patient, accounting for the complex underlying spatial correlation, thereby
increasing power to make improved predictions and treatment decisions.
The VF exhibits a complex spatial structure that is best modeled con-
sidering the anatomy of the eye. Naive spatial/neighborhood structures
that assume neighboring VF locations share information similarly ignore this
anatomy. Incorporating this information can aide in properly modeling this
spatial dependency and in uncovering important features of disease progres-
sion across time. Berchuck et al. (In press 2018) introduced a framework for
inducing localized neighbors as a function of ocular anatomy using a spa-
tiotemporal boundary detection method. Their method utilized a measure
developed by Garway-Heath et al. (2000) that represents an estimate of the
angle that each VF test location’s underlying retinal ganglion cells (RGC)
enter the optic disc. The Garway-Heath angles are used as a dissimilarity
metric, a covariate that explains localized spatial structure. In the present
paper, the methodology from Berchuck et al. (In press 2018) is extended
to the multivariate setting, such that the Garway-Heath angles dictate the
neighborhood structure on the VF for multiple spatial parameters, includ-
ing the spatially varying coefficients and CPs. To our knowledge, this is
the first extension of boundary detection using a dissimilarity metric to the
multivariate setting.
Our newly developed spatial CPs model with multivariate boundary de-
tection structure has the ability to improve prediction of future VF sensi-
tivities and assess progression for a glaucoma patient. Having the ability to
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accurately predict future deterioration of the VF will improve a clinician’s
ability to make timely, data-driven treatment adjustments to preserve vision.
Furthermore, a latent CP process is introduced that allows us to spatially
interpolate CP values at VF locations where visual damage has yet to occur
(i.e., censored locations). This will allow clinicians to determine the location
and timing of future vision loss.
This paper is outlined as follows. Section 2 introduces the VF data while
Section 3 details past CP methods for spatially referenced data. In Section
4, our newly developed spatial CPs method is detailed and we develop a
multivariate boundary detection spatial process for localized smoothing. We
apply our method to a dataset of VF tests from glaucoma patients in Section
5 and present a simulation study in Section 6. We conclude in Section 7 with
a discussion.
2. Visual field data
The visual ability of a glaucoma patient is most often measured through
standard automated perimetry (SAP), an interactive technology that esti-
mates the threshold sensitivity to light across a patient’s field of vision. In
this study, we analyze data acquired with the Humphrey Field Analyzer-II
(HFA-II) (Carl Zeiss Meditec Inc., Dublin, CA), a machine that produces a
visual acuity map across 54 testing locations on the VF. Two of these lo-
cations correspond to a natural blind spot corresponding to the optic disc,
resulting in 52 informative points. During a test, the light is generated with
increasing brightness ranging from approximately 40 decibels (dB) (excellent
vision) to 0 dB (near blindness). The patient uses a hand-held trigger to in-
dicate whether the light stimulus was detected and the machine reports the
dimmest stimulus detected at each location. All stimuli that are not detected
by 0 dB are censored due to the constraints of the machine, as values < 0 dB
are theoretically possible. The resulting gridded spatial layout represents an
estimate of a patient’s visual ability across the entire field of vision at that
point in time.
In the course of monitoring a glaucoma patient, VF testing is performed
on a regular basis and a longitudinal series of VFs is obtained. In Figure 1,
the time series of VF observations is presented for a selected patient from
our data as a motivating example for the CP framework. The majority
of past modeling attempts have assumed a linear relationship between VF
sensitivities and time. However, from the data in Figure 1, it is clear that
4
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Figure 1: Example visual field (VF) time series data for a patient with glaucoma. At each
VF location, the time series of the observed threshold sensitivities is plotted. The trends
and clustering of the time series motivate the use of spatially varying change points.
CPs may provide an improved description of the trajectory of VF sensitivities
over time, and in particular for areas of decreased sensitivities. Furthermore,
the figure illuminates the inverse relationship between VF sensitivities and
testing variability that is well known but rarely modeled in practice (Russell
et al., 2012).
In order to fully motivate the modeling framework, we provide some de-
tails on the anatomy underlying the data generating mechanism for VF data.
The light stimulus from the HFA-II is absorbed by RGCs, which make up
the retinal nerve fiber layer (RNFL) of the retina, that use photoreceptors
to transmit information to the brain along their axons (Davson, 2012). The
RGCs disperse across the RNFL and converge at the optic disc, where the
RGC axons bundle to form the optic nerve. For glaucoma patients, an in-
crease in intraocular pressure creates stress on the optic disc, which in turn
causes RGC death, interrupting the visual pathway to the brain. In particu-
lar, damage to specific regions of the optic disc corresponds to loss of RGCs
whose axons enter the damaged region.
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This anatomy is important to understand when analyzing VF data, be-
cause vision is the brain’s projection of information encoded by RGCs. There-
fore, deterioration of the VF has a direct correspondence to damage of RGCs
that originate from the same region of the retina. Because of this anatomy,
correlation between two test points on the VF is dependent on the spatial
proximity that their underlying RGCs enter the optic disc. This anatomi-
cal relationship was studied by Garway-Heath et al. (2000) who quantified
the relationship between the VF and optic disc by estimating the angle that
each test location’s underlying RGC axons enters the optic disc, measured
in degrees (◦). The measure ranges from 0-360◦, where 0◦ is designated at
the 9-o’clock position (right eye) and angles are counted counter clockwise.
Throughout this analysis, we utilize these angles to properly inform the spa-
tial neighborhood and correlation structure of VF data, in which there is
precedent (Betz-Stablein et al., 2013; Zhu et al., 2014; Warren et al., 2016;
Berchuck et al., In press 2018).
Our newly developed method is applied to data from the Vein Pulsation
Study Trial in Glaucoma and the Lions Eye Institute trial registry, Perth,
Western Australia. The dataset contains 1,448 VF tests from 194 distinct
eyes (98 patients in total). All of the subjects have some form of primary open
angle glaucoma. The mean follow-up time for participants is 934 days (2.5
years) with an average of 7.4 tests per subject. Every VF series is diagnosed
as progressing based on the clinical judgment of two independent clinicians.
In the case that the two clinicians disagree, a third clinician is consulted
(occurred for only 13 VF series). In our study, we have 141 (74%) stable
and 50 (26%) progressing patient eyes. These data have been previously
analyzed (Betz-Stablein et al., 2013; Warren et al., 2016; Berchuck et al., In
press 2018), in which additional details of the data can be found.
3. Change point modeling for spatially referenced data
VF data represent spatially referenced time series that are monitored for
abnormalities that may indicate disease progression. Identifying abruptly
changing variability in time series data was first characterized as a CP prob-
lem by Page (1954) and was used as a quality control method to automatically
detect faults in industrial processes. Although the CP literature is extensive
(Quandt, 1958; Carlin et al., 1992; Julious, 2001), the problem of detecting
the timing of an unknown change in spatially referenced data is relatively
sparse. The core of the literature involves extending the original CP model
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to account for spatial heterogeneity where the original CP model is given as
Yt =
{
β0 + β1xt + t t = 1, . . . , θ,
β0 + β1xθ + β2(xt − xθ) + t t = θ + 1, . . . , ν (1)
where Yt, t = 1, . . . , ν, are observations of the time series, xt is a time varying
regressor (x1 < · · · < xν), and t iid∼ N (0, σ2). The regression parameters β0,
β1, and β2 define a mean process that dictates a piece-wise linear regression
separated at the CP, θ ∈ {1, 2, . . . , ν − 1}, an index of the time series.
With spatiotemporal data, the time series is now observed at a unique spa-
tial location s, {Yt(s), t = 1, . . . , ν}, across the interval [x1(s), xν(s)]. Max-
imum likelihood theory has been developed for the standard CP method of
Equation 1 (Hinkley, 1970), and its many extensions (e.g., multiple CPs), but
more recently, and for spatial methods in particular, the Bayesian paradigm
is preferred (Menzefricke, 1981; Carlin et al., 1992). There have been various
Bayesian CP formulations that account for spatial or spatiotemporal depen-
dencies through adjustments to the intercept (Beckage et al., 2007; Minin
et al., 2007; Yu et al., 2008; Smith et al., 2015; Cai et al., 2016) and ex-
tensions that allow for independent spatial processes before and after the
CP (Majumdar et al., 2005). These methods introduce spatial dependency
using conditional autoregressive (CAR) priors, a Gaussian Markov random
field that induces neighborhood dependencies across the region (Besag, 1974;
Geman and Geman, 1984).
In the context of Equation 1, this implies that spatial dependencies
are most often modeled through adjustments to the intercepts, now spa-
tially referenced as β0 + β0(s). In particular, this implies the following con-
ditional prior form, β0(si)|β0(sj 6=i), τ 2 ind∼ N
(∑m
j=1wijβ0(sj)/wi+, τ
2/wi+
)
,
where wij = 1(i ∼ j) is an indicator equal to one if locations i and j are
neighbors and wi+ =
∑m
j=1wij is the number of neighbors for location i. This
conditional prior distribution has an intuitive interpretation as the mean is
an average of the neighboring values and the variance decreases as the num-
ber of neighbors increases (Banerjee et al., 2003). Although the CAR prior
is an effective method for modeling spatial variability for areal data, these
previous methods ignore the spatial variability in the CPs themselves.
In a recent study, Wagner and Midway (2014) introduced a model with
spatially varying intercepts, slopes, and CPs. In their method, there is
a unique CP at each spatial location and additionally, the process is re-
parameterized so that the CP parameter is continuous. The general form of
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the mean structure (after applying the appropriate link function) is given as
µt(s) =
{
β0(s) + β1(s)xt(s) xt(s) ≤ θ(s),
β0(s) + β1(s)θ(s) + β2(s){xt(s)− θ(s)} xt(s) > θ(s). (2)
In this specification, the CP θ(s) is no longer an index of the time series and
instead ranges in [x1(s), xν(s)]. In Wagner and Midway (2014), after rescal-
ing the CPs to the real line, the regression parameters and CPs are modeled
jointly using a multivariate Gaussian distribution centered at a vector of fixed
effects with an unstructured cross-covariance matrix. The authors assumed
independence across space in their model specification. Subsequently, this
method has been extended to account for spatial dependency using a multi-
variate CAR (MCAR) process (Warren et al., 2017). The MCAR allowed for
an improved modeling framework by accounting for both spatial variability
and cross-covariance in the location specific intercepts, slopes, and CPs.
4. Methods
Following the approach of Warren et al. (2017), we propose extending the
general CP framework by introducing a set of spatially varying intercepts,
slopes, and CPs that are modeled with an MCAR process. This increased
flexibility allows us to accurately describe the individual time series behavior
at each unique spatial location while accounting for spatial correlation and
cross-covariance between the parameters that may result in increased power
to detect important changes.
However, we extend the existing framework in a number of ways. First, we
also allow for a CP (and spatially varying regression coefficients) in the model
for the nuisance (or variance) parameter to reflect the situation where the
observed data become more or less variable after a CP occurs. Next, we define
the observed CP at a specific spatial location as a function of a potentially
censored latent CP process (also spatially varying). This flexible specification
permits spatial interpolation of currently censored or unobserved CPs across
the spatial domain. This becomes particularly useful when working with data
where the CPs describe the timing of treatment failure or an adverse event.
Finally, a novel boundary detection MCAR process is developed that allows
for a dissimilarity metric in the spatial covariance definition. Inference for
this model is based on Markov chain Monte Carlo (MCMC) simulation, and
a description of the algorithm is given in Appendix A. The newly introduced
model is computationally intensive, so the MCMC algorithm is implemented
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using Rcpp (Eddelbuettel et al., 2011) and is available from the R package
spCP (R Core Team, 2016).
4.1. Spatially varying change points model
We begin by describing our new methodology generally before applying
it to VF data in Section 5. The general framework is flexible enough to
accommodate many different spatially referenced time series data settings.
Let Yt (s) be an observation from spatial location s at time xt (s), for {si : i =
1, . . .m}, t = 1, . . . , ν, where the times are strictly increasing. An extension
of Equation 2, we introduce a model that allows for location specific CPs,
intercepts, and slopes in the mean and nuisance parameter processes of the
data such that
Yt(s)|µt(s), ζt(s) ind∼ f (µt(s), ζt(s)) , g1{µt(s)} = γt(s), g2{ζt(s)} = ωt(s)
γt(s) =
{
β0(s) + β1(s)xt(s) xt(s) ≤ θ1(s)
β0(s) + β1(s)θ1(s) + β2(s) {xt(s)− θ1(s)} xt(s) > θ1(s) (3)
ωt(s) =
{
λ0(s) + λ1(s)xt(s) xt(s) ≤ θ2(s)
λ0(s) + λ1(s)θ2(s) + λ2(s) {xt(s)− θ2(s)} xt(s) > θ2(s).
The form of Equation 3 is an extension of Equation 2 with a general likeli-
hood, f , and a CP in the nuisance process. The mean process is modeled
through a link function, g1(·), and thus can be non-linear. The nuisance pa-
rameters are partitioned into constant terms and a location and time specific
component, such that ζt(s) = {ζt(s), ζ}. The CP for the nuisance parameter
is introduced similarly as for the mean process, through the link function
g2(·). At each spatial location, the CP for the mean process, θ1(s), and
nuisance parameter process, θ2(s), are unique.
Allowing for a continuous valued CP is important because we generally
do not expect the change to occur discretely during one of the observed
time points, particularly when there is a large amount of time between ob-
servations. The specification can be improved however, through a natural
assumption about the censoring of CPs at the edges of the observed time
period. In particular, when θj(s) = x1(s), j = 1, 2, the CP has occurred
before the time series at location s was monitored, while θj(s) = xν(s) in-
dicates that the CP has not yet occurred by the end of the follow-up pe-
riod. As such, both the lower and upper bounds of the CP are censored.
To account for this, we model the observed CP as a function of the under-
lying and potentially unobserved true latent CP process, ηj (s), such that
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θj(s) = max{min{ηj(s), xν(s)}, x1(s)} where ηj(s) has support on the real
line and is allowed to vary spatially. This framework gives us the ability
to spatially interpolate latent CP parameters that have yet to occur which
could be important in some applications for determining when and where
future damage can be expected.
4.2. Multivariate dissimilarity metric spatial process
In order to account for the potentially complex spatial correlation and
cross-covariance between the introduced spatially varying intercepts, slopes,
and CPs, we develop a novel boundary detection MCAR model that al-
lows for a dissimilarity metric within the framework introduced by Mardia
(1988). Incorporating the dissimilarity metric into the framework is im-
portant for correctly modeling areal spatial data where the neighborhood
structure of the region is uncertain and controlled by a set of underlying
factors (e.g., VF data). Similar to the CAR process, the MCAR introduces
spatial dependencies through a Markov random field technique, and is in
fact a multivariate generalization of the CAR with a seperable covariance.
Since Mardia (1988), the MCAR has seen numerous developments through-
out the years that have generalized the seperable assumption (Gelfand and
Vounatsou, 2003; Jin et al., 2005, 2007). Although there may be motivation
for a non-seperable process, in this paper we introduce our boundary detec-
tion technique within the standard MCAR. This could easily be generalized
to a non-seperable process using the linear model of coregionalization.
Similar to the univariate case, the joint distribution of the parameters is
derived from their full conditional distributions. Under the Markov random
field assumption, these conditional distributions can be specified as follows,
f (φi|φj 6=i,µ,Γi) = MVN
(
µi +
∑
i∼j
Bij(φj − µj),Γi
)
, i, j = 1, . . . ,m
where φi = (φi1, φi2, . . . , φip)
T and µi = (µi1, µi2, . . . , µip)
T are p-dimensional
vectors, µ = (µT1 ,µ
T
2 , . . . ,µ
T
m)
T, and Γi and Bij are p × p matrices. Using
Brook’s lemma (Brook, 1964), Mardia proved that the full conditional distri-
butions uniquely determine the joint distribution given by f (φ|µ, {Γi}) ∝
exp
{
−1
2
(φ− µ)TΓ−1(Imp − B˜)(φ− µ)
}
, where φ = (φT1 ,φ
T
2 , . . . ,φ
T
m)
T, Γ
is a block diagonal matrix with blocks Γi and B˜ is an mp×mp matrix with
(i, j)-th block Bij. Different MCAR forms can be obtained through various
Γ and B˜.
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In this case, we induce an MCAR structure that generalizes the univari-
ate version of the Leroux CAR specification, thus allowing the dissimilar-
ity metric to be used in a multivariate setting (Leroux et al., 2000; Mac-
Nab and Gustafson, 2007; Lee and Mitchell, 2011). As in the univariate
case, symmetry of Γ−1(Imp − B˜) is required. A convenient special case sets
Bij = bijIp. Under this condition, the multivariate version of the Leroux dis-
similarity metric likelihood can be obtained with the following specifications,
bij = ρwij (α) ∆
−1 and Γi = Σ∆−1, where ∆ = ρ
∑m
j=1 wij (α)+(1−ρ). Spa-
tial neighborhood structure is introduced through the adjacencies {wij(α)}.
The adjacencies are defined similar to the specification in Berchuck et al.
(In press 2018). In particular, they are a function of a dissimilarity metric
and regression parameter such that wij(α) = 1{i ∼ j} exp{−zijα} where
i ∼ j is the event that locations i and j share an edge or corner (wii = 0 for
all i). The quantity zij is a measure of (dis-)similarity between two locations
and is defined as zij = |zi − zj|, where zi is a covariate at location si. The
parameter α is forced to be non-negative, so that the adjacencies are in the
open unit interval, and this is in fact a condition for guaranteeing a valid
covariance.
This specification induces a multivariate version of the conditional distri-
butions which is analogous to the univariate Leroux likelihood and is given
as f (φi|φj 6=i, δ,Σ, α, ρ) =
MVN
(
ρ
∑m
j=1wij (α)φj + (1− ρ)δ
ρ
∑m
j=1 wij (α) + (1− ρ)
,
Σ
ρ
∑m
j=1wij (α) + (1− ρ)
)
where µi = δ, so that the mean is constant across spatial locations. The
distribution for the joint specification can be established by noting that
Γ−1(Imp − B˜) = Q (α, ρ) ⊗ Σ−1, with Q(α, ρ) = ρW∗(α) + (1 − ρ)Im. The
matrix W∗ (α) has diagonal elements w∗ii (α) =
∑m
j=1wij (α) and off-diagonal
elements w∗ij (α) = −wij (α). Finally, this form of the adjacencies yields the
joint distribution f (φ|δ,Σ, α, ρ) ∼ MVN (1m ⊗ δ,Q (α, ρ)−1 ⊗Σ). We de-
note a random variable φ with this distribution as φ ∼ MCAR(α, ρ, δ,Σ).
4.3. Hyperprior distributions
To complete the model specification, we select prior distributions for the
hyperparameters. The prior for the mean δ, covariance Σ, and boundary
detection parameter α are as follows;
δ ∼ N (0, κ2Ip) , Σ ∼ Inverse-Wishart(ξ,Ψ), and α ∼ Uniform (aα, bα) .
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The mean δ is zero centered with variance, κ2, which is chosen to be large in
order to yield a weakly informative prior. For the prior on Σ, we specify an
inverse-Wishart distribution with degrees of freedom ξ = p+1 and scale ma-
trix, Ψ = Ip, where p is the dimension of the spatial parameter, φi. This prior
induces marginally uniform priors on the correlations of Σ and allows for the
diagonals to be weakly informative (Gelman et al., 2014). The dissimilarity
metric parameter, α, is forced to be non-negative with a uniform distribu-
tion. The bounds are defined as aα = 0 and bα = − log{0.5}/mini,j{zij}. As
in Lee and Mitchell (2011), the upper limit is set so that the smallest dis-
similarity metric between two locations can still obtain a spatial adjacency
of 0.50.
We fix ρ at 0.99 to force spatial dependency, in which there is prece-
dent (Lee and Mitchell, 2011; Berchuck et al., In press 2018). In particular,
Berchuck et al. (In press 2018) demonstrated that ρ fixed at 0.99 has little im-
pact on estimation of α. Multivariate spatial structure is introduced through
φi = {β0 (si) , β1 (si) , β2 (si) , η1 (si) , λ0 (si) , λ1 (si) , λ2 (si) , η2 (si)}T, which
are assigned an MCAR(α, 0.99, δ,Σ) process.
5. Monitoring visual field progression
5.1. Change points model for visual field data
We modify the general form of the model described in Section 4 for the
purpose of monitoring a patient’s VF data across space and time with the goal
of improving disease management. Using the notation developed in Section
4, we define Y ∗t (s) as the observed VF sensitivity at VF location s and xt
days after the baseline visit (x1 = 0), for {si : i = 1, . . . 52}, t = 1, . . . , ν,
where the number of visits, ν, is patient specific. Note that since the timing
of visits is the same for all VF locations for a single patient, xt(s) ≡ xt.
Furthermore, the number of VF locations, 52, represents the total number of
locations on the VF after removing the two corresponding to the blind spot.
The data generating mechanism for VF sensitivities is such that obser-
vations are censored at zero due to limitations of the machine that collects
the data. Therefore, we use a Tobit model (Tobin, 1958), in which there
is precedent in the glaucoma progression literature (Betz-Stablein et al.,
2013; Bryan et al., 2015; Berchuck et al., In press 2018). To induce the
Tobit model, we define a latent process through the standard Tobit link,
Y ∗t (s) = max {0, Yt(s)}, where Yt(s) = µt(s) + t(s), t(s) ind∼ N (0, σ2t (s)).
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This is a special case of Equation 3 where ζt(s) = σ
2
t (s), g1(·) is the identity
link, and g2(·) = log{
√{·}}.
To appropriately model the course of glaucoma progression, we modify the
mean and variance structures. Patients with glaucoma are typically stable
until the point of progression when their VF time series begin to deteriorate
(see Figure 1 for example). As such, for VF data we define the mean process
so that at times before the CP there is a constant intercept at each VF
location. To accomplish this, we set β1(s) = 0 in Equation 3. The same
assumption is used for the variance process, so that the variance can increase
with the onset of deterioration (i.e., λ1(s) = 0). Furthermore, motivated
by the disease course, we force the CPs in the mean and variance to occur
simultaneously, θ(s) ≡ θ1(s) = θ2(s). To finalize the model, we specify
hyperpriors based on details in Section 4.3, where κ2 = 1000 and p = 5. We
define the dissimilarity metric, zi, as the Garway-Heath angle at VF location
si.
We draw samples from the joint posterior by utilizing MCMC techniques
(Metropolis et al., 1953; Geman and Geman, 1984; Gelfand and Smith, 1990).
Many of the parameters have conjugate full conditionals. In particular, all
of the parameters have closed form solutions, with the exception of α, λ0(s),
λ2(s), and η(s). A Gibbs sampler is used with Metropolis steps for parameters
lacking conjugacy. For each eye, the MCMC sampler is run for 250,000
iterations after a 10,000 burn-in and thinned to a final sample size of 10,000.
There were no obvious signs of non-convergence observed for any of the 191
VF series based on traceplots and the Geweke statistic (Geweke, 1992). The
MCMC sampler is implemented in the R package spCP. More details about
the MCMC sampler can be found in Appendix A.
5.2. Model comparison
In order to establish the capability of the introduced model to predict
VF sensitivities, predict the location and timing of future vision loss, and
diagnose glaucoma progression, we compare it to a number of competing
models with varying levels of complexity:
1. Point-wise linear regression (PLR): Independent Tobit linear regression
at each location.
2. Non-spatial CP (D): Tobit linear regression with discrete CPs, based
on Equation 1.
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3. Non-spatial CP (C): Tobit linear regression with continuous CPs,
where the CPs at each VF location are independent and uniformly
distributed a priori.
4. Non-spatial CP (L): Tobit linear regression with continuous CPs and an
underlying normally distributed latent process, as specified in Section
4.1.
5. Spatial CP : Spatial CPs model detailed in Section 5.1.
Each of the competing CP models specify a constant process before the
CP, as specified in Section 5.1. In addition, each of the models utilize the
Tobit likelihood in order to gain an understanding of key differences in their
performance due to other factors. The motivation of fitting the simplified
models, such as PLR and basic CP models, is to have a benchmark for
comparison and to emphasize the importance of the latent CP specification
and spatial structure. Note that each of the models are subsets of Spatial
CP.
The models are compared using model fit diagnostics and hold-out predic-
tion criterion. To assess model fit, the deviance information criterion (DIC)
is used (Spiegelhalter et al., 2002). For prediction, the final visit for each
of the VF series is held out, and the remaining visits are used to predict
the hold-out visit. Prediction accuracy is measured using the mean squared
prediction error (MSPE). Smaller values of DIC and MSPE are preferred.
The model fit and prediction diagnostics can be found in Table 1 averaged
over all patients. The DIC for Spatial CP is superior to the rest of the models,
with a minimal value of -53.74. Generally, there is a monotone decreasing
trend in DIC as the models become more complex. The number of effective
parameters also trends smaller with added model complexity, indicating that
the added model structure provides a more concise framework for modeling
VF data. The prediction measure also favors Spatial CP, with optimal MSPE
of 0.13. MSPE for the three non-spatial CP models is inferior to PLR,
indicating that the inclusion of a CP does not guarantee improved prediction.
Only when accounting for the spatial nature of VF data does a CP model
offer improved prediction over PLR, again illuminating the importance of
modeling spatial variability. Overall, the results in Table 1 indicate that
Spatial CP has superior model fit and prediction ability for VF data.
5.3. Diagnosing progression using change points
To illustrate the superiority of the introduced methodology, in addition
to model fit and prediction, we demonstrate the diagnostic capability of the
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Table 1: Model fit and prediction diagnostics for model comparison. Model fit is deter-
mined using the deviance information criterion (DIC) and effective number of parame-
ters (pD). Prediction capability is determined using the mean squared prediction error
(MSPE). The ability of each model to diagnose progression is assessed using a metric de-
pendent on the latent change points (CPs). For each model with a latent CP process, the
metric maxi{P [θ(si) < tν |Y]} is calculated and regressed against the clinically determined
progression status. Diagnostic capability is measured using Akaike information criterion
(AIC), area under the receiver operating characteristic curve (AUC), and the p-value for
each measure.
Model Fit Prediction Diagnostic
Model DIC pD MSPE AIC AUC p-value
PLR 31.11 120.30 0.20 — — —
Non-spatial CP (D) -14.27 119.30 0.45 — — —
Non-spatial CP (C) -18.76 112.13 0.32 — — —
Non-spatial CP (L) -29.05 67.69 0.23 211.36 0.64 0.001
Spatial CP -53.74 68.21 0.13 208.67 0.69 <0.001
CPs. We hypothesize that the location of the CPs can serve as a proxy for
disease progression and propose a diagnostic metric that is a function of the
posterior probability that a CP has occurred up to the last VF visit, pi =
P [θ(si) < tν |Y]. We define the final metric for a patient eye as the maximum
across all VF probabilities, max{pi : i = 1, . . . , 52}. This is intuitive because
a longitudinal series of VFs with earlier occurring CPs is more likely to be
progressing.
In order to assess the diagnostic ability of the CPs, we construct logistic
regression models, regressing the defined metric on the clinical assessment of
progression and present Akaike information criterion (AIC), area under the
receiver operating characteristic curve (AUC), and a p-value for the slope
parameter. These measures are presented in Table 1 for models that have
a latent CP process (the only models capable of estimating the CP proba-
bility). From Table 1, it is clear that the CPs arising from Spatial CP are
highly associated with progression (p-value: < 0.001). The non-spatial model
also yields a significant slope estimate, however the p-value is of a different
magnitude (p-value: 0.001). Furthermore, the values of AIC and AUC are
optimized under Spatial CP with minimal AIC, 208.67, and maximal AUC,
0.69. These results help validate the claim that the CPs are representative
of disease progression and that their estimates are clinically useful.
To further illustrate the diagnostic ability granted by the latent CP frame-
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Figure 2: Demonstrating the ability of Spatial CP to identify change points (CPs) that
have yet to occur. At each cell, the observed DLS are presented for an example patient
with nine visits. Based on only the first seven visits, the posterior density estimates of
the CPs for Spatial CP and Non-spatial CP (L) are presented as density estimates in blue
and green lines, respectively. The estimated CP based on Spatial CP using all of the nine
VF visits are presented as dashed vertical lines. The DLS and CPs are shown in red if
they occur after the seventh visit and thus are not observable at the time the posterior
densities were estimated.
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work, we present an example patient as a proof of concept. This patient’s
information is appropriate for investigation because they have late occurring
CPs that are truncated when removing visits near the end of follow-up. The
patient has nine VF visits, however we only use the initial seven to fit Spa-
tial CP and spatially interpolate the latent CPs. We then compare these
predictions with the actual CPs estimated using the full set of data (i.e., all
nine visits). The patient’s VF data are presented in Figure 2, where at each
location the first seven VF sensitivities are shown using black dots and the
last two are shown in red. Furthermore, the mean CPs estimated by Spatial
CP for the full data are presented as dashed vertical lines. Any CP that
was estimated to have occurred after the seventh visit is colored red and is
technically truncated for purposes of clinical use at visit seven. Finally, the
posterior latent CP density estimates (based on the reduced data) for Spatial
CP and Non-spatial CP (L) are presented as density estimates in blue and
green, respectively.
From Figure 2 it is clear that Spatial CP is capable of predicting future
CPs that have not been observed. This is remarkable, since at the seventh
visit there was no clear sign of a CP at many of these locations and fur-
thermore, Non-spatial CP (L) performed poorly, indicating the importance
of spatial structure. To quantify the conclusions drawn from Figure 2, for
each model we present diagnostics for prediction of the estimated CPs. Each
model is compared to the “true” CPs estimated from the same model with
full data. Spatial CP and Non-spatial (L) have MSPE of 4.70 and 8,525.82,
respectively, indicating Spatial CP provides superior prediction of the unob-
served CPs. These powerful results indicate that the introduced methodol-
ogy has the capability of predicting future unobserved CPs, and therefore
progression. This is possible due to both the latent CP specification and
multivariate spatial boundary detection structure. As shown in Table 1 and
Figure 2, without either of these specifications the model suffers in terms of
model fit, prediction, and diagnostic capability.
5.4. Clinical implementation
Having established the potential for using Spatial CP in the clinical set-
ting for prediction of VF sensitivities and CPs, we now present example
output for use clinically. In Figure 3, on the left, the posterior fitted trend
is presented on the VF with the estimated posterior CPs. The plot presents
the estimated regression mean (with 95% credible intervals) and CPs for the
same example patient in Figure 1. The mean process is presented in red
17
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Figure 3: Output generated from Spatial CP. The plot on the left presents the estimated
mean (with 95% credible intervals) and CPs for the same example patient in Figure 1.
The mean process is presented in red and the change points are vertical blue lines. The
panel on the right presents the posterior probability of an observed CP at each location
on the VF.
and the CPs are vertical blue lines. This figure demonstrates the flexibility
of Spatial CP to produce non-linear trends, not simply two lines connected
at a point. This type of trajectory is a result of the CPs being unknown
quantities. In addition to the predicted fit, it is useful to have a heatmap of
the posterior probability that each of the CPs have occurred in the observed
data (right panel of Figure 3). This presentation corresponds to the esti-
mated CPs in the left frame, but further provides a useful map for clinicians
to understand the location and severity of progression.
Both of these plots in conjunction with the diagnostic potential from Spa-
tial CP provide a useful framework for clinicians to assess progression. This
presentation is clinically useful, and can be further improved when presented
in video format. In Video B.1, the heatmap of Figure 3 is presented over
the full course of follow-up and into the future to provide clinicians an un-
derstanding of the disease pattern and growth over time and into the future.
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The combination of the latent CP process and novel spatial structure has
produced a technique that goes beyond the simple CP models and PLR in
terms of model fit, prediction, and progression diagnoses.
6. Simulation study
The purpose of the simulation study is to investigate the performance
of Spatial CP and the comparison models detailed in Section 5.2 under dif-
ferent data generating scenarios. The scenarios are all subsets of the joint
spatial structure, MVN
(
1m ⊗ δ,Q (α, 0.99)−1 ⊗Σ
)
, with parameters chosen
to reflect those from an actual analyzed glaucoma patient:
δ =

25
−15
−0.5
0.1
0.5
 , Σ =

0.025 −0.500 −0.500 −0.500 0.500
−0.500 0.025 0.500 0.500 −0.500
−0.500 0.500 0.025 0.250 −0.500
−0.500 0.500 0.250 0.025 −0.500
0.500 −0.500 −0.500 −0.500 0.025
 , (4)
and α = 0.10. Based on these true parameters, we create five data generating
settings: (1) Progressing: CPs have all occurred before the beginning of
follow-up; (2) Stable: CPs have yet to occur; (3) Non-spatial CPs: CPs are
observed throughout follow-up in the mean and variance process with no
spatial dependency; (4) Spatial CPs with no covariance: spatially dependent
CPs are observed throughout follow-up in the mean and variance process
with no cross-covariance in the spatial effects; (5) Full spatial CP model:
spatially dependent CPs are observed throughout follow-up in the mean and
variance process with spatial cross-covariance.
Settings 1-4 are obtained by changing components of δ, Σ, and α. For
Settings 1 and 2, α is fixed at an arbitrarily large value, 1000, to remove
spatial dependency, and Σ is restricted to being diagonal, with the fourth
entry equal to zero to remove a CP in the variance. This specification yields
the PLR model as long as the CPs are not observed. As such, Setting 1 is
obtained by fixing the fifth entry in δ to an arbitrarily large negative value,
-10, while a large positive value, 10, is used for Setting 2. To guarantee no
CP in the variance, the fourth entry in δ is fixed at zero. Setting 3 introduces
a CP in the variance process by using the specification of δ from Equation 4
and the fully diagonal Σ. The value of α is still fixed at 1000, so that there is
no spatial dependence. Setting 4 is obtained by specifying Σ to be diagonal
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and represents a spatial CP model with no cross-covariance between spatially
referenced effects. Setting 5 uses the full parameter specification.
A new dataset is generated for each simulated vector of φ to ensure that
the results are not affected by a particular realization. For each setting, we
simulate data based on a set of known hyperparameters and then fit each
model to the same dataset to assess model fit, prediction, and estimation of
CPs (both latent and observed). As in Section 5, for model fit we utilize
DIC and pD for exploring explanatory ability of each model, and MSPE for
prediction. The framework for assessing prediction is innately linked to how
the data were simulated. Each dataset was simulated assuming there were
21 VF visits (the maximum number of visits in our study data), however, the
models were only fit to the first 14 visits. This allows us to use the last 7 visits
for prediction assessment. The visit times were specified as the sequence of
numbers between 0 and 1 by a 0.05 increment. Finally, estimation of both
the observed CPs and latent CPs process are assessed using bias, MSE, and
empirical coverage (EC) of the Bayesian credible intervals. In this context,
the EC is the proportion of the simulated datasets where the calculated 95%
credible interval contains the true parameter value.
The results from the study are displayed in Tables 2, 3, and 4 and relate to
250 simulated data sets for each setting. In Table 2, the model fit diagnostics,
DIC, and pD, are presented for the five models across all data generating
settings. As expected, the models all have generally similar DIC values for
the first two settings, which are just progressing and stable representations
of PLR. As the data generating settings increase in model complexity, the
DIC value corresponding to Spatial CP separates from the non-spatial CP
models and PLR. The effective number of parameters, pD, is similar for all
models in Setting 1, but is generally smaller for Spatial CP and Non-spatial
CP (L) for the remaining settings. It is encouraging that Spatial CP has a
smaller pD in the more complex settings, indicating that the increased model
structure maintains parsimony even in the presence of complex data.
Next, we studied the capability of each model to predict future VF sen-
sitivities. Prediction ability was assessed for each model by predicting the
simulated data for the final 7 visits excluded from the modeling. In Table
3, we present results for two of these visits. For Setting 1, MSPE shows
similar values for most models within each time point with the exception of
Spatial CP which is superior to the competing methods. This is surprising,
since this data generating setting is a subset of each of the competing mod-
els, but possibly indicates that Spatial CP is preferred even in the absence
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Table 2: Model fit diagnostics for the simulation study. The diagnostics included are
deviance information criterion (DIC) and effective number of parameters (pD) and are
presented for each of the models introduced in Section 5.2. The data generating settings
for the simulation increase in model complexity and are as follows, 1) progressing, 2)
stable, 3) non-spatial CP, 4) spatial CP with no covariance, and 5) full spatial CP model.
Each reported estimate is based on 250 simulated datasets.
Simulation Setting
Metric Model 1 2 3 4 5
DIC PLR -466.33 -409.93 -360.16 -401.16 -276.76
Non-spatial CP (D) -457.89 -434.85 -426.27 -455.50 -293.29
Non-spatial CP (C) -412.21 -442.09 -414.03 -448.02 -293.54
Non-spatial CP (L) -473.37 -476.06 -446.44 -446.77 -318.36
Spatial CP -479.61 -455.21 -457.57 -468.10 -351.22
pD PLR 118.23 118.39 118.59 121.08 118.72
Non-spatial CP (D) 111.19 118.51 117.44 134.85 125.36
Non-spatial CP (C) 133.70 105.29 120.37 135.56 115.00
Non-spatial CP (L) 109.34 69.65 87.82 78.27 77.70
Spatial CP 118.80 92.41 110.22 94.71 90.56
of clear spatial structure. In Setting 2, all of the models have comparable
performance, while in Settings 3 and 4, Spatial CP generally shows small
improvements. Finally, in the most complex setting, Spatial CP has superior
prediction ability at both future visits.
Finally, we investigate the ability of each model to estimate both the
observed, θ(s), and latent, η(s), CPs. In Table 4, we present bias, MSE,
and EC for models that are capable of estimating either of these CPs. Note
that Non-spatial CP (D) was not included in the observed CP section since
it is estimating a different, discrete, CP. The results for estimating the ob-
served CP demonstrate the importance of the latent CP process for properly
modeling the true CP. The most important finding in these results is that
Non-spatial CP (C) is incapable of estimating the observed CP, with inferior
bias, MSE, and EC. In particular, the EC is estimated to be zero for Settings
1-2. This is clearly due to the lack of a latent CP specification, as the two
models with this feature have improved EC. Finally, it is important to note
that Spatial CP has superior bias and MSE in estimating the observed CPs,
indicating that in addition to the latent CPs, spatial structure is also crucial.
In the simulation study for estimation of the latent CPs, only Spatial
CP and Non-spatial CP (L) are compared (i.e., the only models with latent
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Table 3: Prediction diagnostics for estimation of the visual field (VF) visits at future times
0.75 and 1. Mean squared prediction error is presented for each of the models introduced in
Section 5.2. The data generating settings for the simulation increase in model complexity
and are as follows, 1) progressing, 2) stable, 3) non-spatial CP, 4) spatial CP with no
covariance, and 5) full spatial CP model. Each reported estimate is based on 250 simulated
datasets.
Simulation Setting
Time Model 1 2 3 4 5
0.75 PLR 215.14 577.70 450.40 358.81 531.48
Non-spatial CP (D) 213.56 572.25 447.12 364.53 532.32
Non-spatial CP (C) 215.35 577.26 451.93 362.37 531.95
Non-spatial CP (L) 213.62 577.54 451.17 359.04 530.65
Spatial CP 187.63 577.25 439.73 349.58 524.76
1 PLR 131.81 573.39 451.89 248.02 541.26
Non-spatial CP (D) 129.24 558.73 443.05 258.77 539.04
Non-spatial CP (C) 132.91 573.20 455.12 254.08 542.85
Non-spatial CP (L) 131.47 574.85 452.77 247.87 541.05
Spatial CP 109.62 575.05 443.39 239.76 527.46
CPs). It is immediately clear that the inclusion of spatial structure is critical
for estimating the latent CPs. In all simulation settings, the bias and MSE
are improved for Spatial CP. The bias and MSE are generally larger in the
Settings 1-2 because there are no observed CPs in the generated data. From
Table 4 it is clear that Spatial CP is needed for accurately estimating both
the latent and observed CPs.
Finally, an additional simulation study is presented in Appendix C to
demonstrate the performance of Spatial CP in estimating the observed CP
across various points of follow-up. In Figure C.1 and Table C.1, the results
illustrate the importance of Spatial CP, especially in models with CPs near
the bounds of follow-up.
7. Discussion
In this paper, we presented a unified framework that combines multiple
vital aspects of glaucoma management; i) prediction of future VF sensitivi-
ties, ii) predicting the timing and spatial location of future vision loss, and
iii) making clinical decisions regarding progression. Furthermore, this frame-
work incorporates important anatomical information. Previous statistical
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Table 4: Summary diagnostics for estimation of the observed, θ(s), and latent, η(s),
change points (CPs). The diagnostics included are bias, mean squared error (MSE)),
and empirical coverage (EC) (95% nominal) and are presented for each of the models
introduced in Section 5.2 that are capable of estimating either the observed or latent CP.
The data generating settings for the simulation increase in model complexity and are as
follows, 1) progressing, 2) stable, 3) non-spatial CP, 4) spatial CP with no covariance, and
5) full spatial CP model. Each reported estimate is based on 250 simulated datasets.
Simulation Setting
EstimandMetricModel 1 2 3 4 5
θ(s) Non-spatial CP (C) -0.11 0.19 0.07 0.07 0.09
Bias Non-spatial CP (L) -0.00 0.06 0.01 0.04 0.01
Spatial CP -0.00 0.00 0.00 0.01 0.00
Non-spatial CP (C) 0.02 0.07 0.05 0.03 0.05
MSE Non-spatial CP (L) 0.00 0.04 0.03 0.04 0.04
Spatial CP 0.00 0.00 0.00 0.01 0.00
EC
Non-spatial CP (C) 0.00 0.00 0.16 0.58 0.16
Non-spatial CP (L) 1.00 1.00 0.98 0.90 0.98
Spatial CP 1.00 1.00 0.98 0.97 0.99
η(s)
Bias
Non-spatial CP (L) 16.00 -17.69 -3.82 -11.18 -18.99
Spatial CP -1.59 1.01 -0.00 -0.01 0.01
MSE
Non-spatial CP (L) 4088.015399.534615.014453.895531.15
Spatial CP 33.33 26.85 1.90 0.04 0.56
EC
Non-spatial CP (L) 0.99 0.99 0.90 0.84 0.96
Spatial CP 0.85 0.84 0.90 0.91 0.95
work has focused on one or some of these aspects typically, but to our knowl-
edge, no methods have considered all simultaneously; in particular the latent
CP process. Although motivated by VF data, the methodology was intro-
duced in a general manner that permits the model to be applied in broad
areal data settings where a CP is appropriate. The methodology is built
upon theory in the CP literature, utilizing a Bayesian hierarchical modeling
framework for making inference.
We extended previous attempts at modeling CPs across spatial units,
that either ignore spatial dependencies (Wagner and Midway, 2014) or do
not include a CP in the variance process (Warren et al., 2017). The inclusion
of the variance CP process can add power to detect CPs and was motivated
by the known inverse relationship between decreases in VF sensitivity and
variability (Russell et al., 2012). Finally, we extended the univariate spatial
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boundary detection framework for allowing a dissimilarity metric to dictate
the local neighborhood structure on the VF. The novel multivariate extension
allows the anatomy of the optic disc to dictate the neighborhood adjacen-
cies for the mean, variance, and CP processes. This specification functions
jointly and accounts for known dependencies between the separate processes
through a cross-covariance. The combination of these model features leads
to a superior modeling technique for longitudinal series of VFs.
The results from applying our method to VF data (Section 5) demon-
strated the benefit of our methodology in both prediction of future VF sen-
sitivities and model fit. Spatial CP was compared to non-spatial CP models
and PLR and was shown to have superior DIC and MSPE (Table 1); this
was later confirmed in simulation (Tables 2 and 3). These results indicate
the promise of Spatial CP clinically, as predicting future VF sensitivities is
incredibly important for managing progression (Crabb et al., 1997). These
improvements can be attributed to the inclusion of a spatial dependency
structure and the flexible trajectories produced by the CPs across time. The
need for spatiotemporal treatment of VF data is demonstrated here by a
reduction in prediction errors and observed clinically meaningful results.
In addition to an increase in prediction precision, the CP framework al-
lows for prediction of the timing and spatial location of future vision loss.
This information is accessible due to both the modeling of spatial depen-
dencies and the latent specification of the CP. The benefits of the latent CP
are that it provides a biological interpretation of true disease progression
and informs about VF sensitivity outside of the observed follow-up period.
The latent CP is modeled using the novel multivariate spatial process, which
allows the anatomy of the optic disc to dictate the local neighborhood struc-
ture. As such, the patterns of future vision loss based on the latent CP are
anatomically driven. This can be seen in the estimated probabilities of a
CP for an example patient (right panel of Figure 3 and Video B.1), which
display a clear differentiation in the inferior and superior sectors as defined
by Garway-Heath et al. (2000). The practical utility of this latent CP speci-
fication is rooted in the biological motivation, but also in that it provides an
alternate method for predicting severity across the VF.
The latent CP clearly represents an improvement over standard CP spec-
ifications that limit the range of the CP to the observed follow-up period.
Furthermore, it allows us to predict a unobserved CPs. This was exemplified
with an example patient with many observed CPs near the end of follow-up.
For this patient, we showed that when removing the last two visits (and thus
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truncating these CPs), Spatial CP was still capable of detecting the pres-
ence of an imminent CP. This served as a proof of practice for predicting
unobserved CPs and was facilitated by the spatial correlation between VF
locations, as Non-spatial CP (L) was incapable of detecting these truncated
CPs (Figure 2). This was further confirmed in simulation, as Spatial CP
estimated the latent CP with lower bias and MSE (Table 4).
We defined a diagnostic metric as the maximum probability across the
VF of a CP occurring in the observed follow-up period and showed that it
is a significant predictor of clinically determined glaucoma progression (Ta-
ble 1). This contribution is important clinically, since a detectable change
in a longitudinal series of VFs can be highly suggestive of progression, even
if standard VF metrics may appear well within normal limits (Artes and
Chauhan, 2005). This finding supports the hypothesis that a CP can in-
trinsically parameterize the timing of progression. Furthermore, it confirms
the importance of Spatial CP for characterizing structural change on the VF
that can be used for improved clinical decision making.
This paper introduced a framework for assessing glaucoma progression
from numerous angles and demonstrates the clinical utility of CPs acting as
a proxy for disease progression. To validate these findings it will be important
to compare the diagnostic efficiency of the CPs to other established metrics
in the glaucoma progression literature, in addition to the ones presented here.
Furthermore, the estimation of progression can be improved when combin-
ing functional (e.g., VF) and structural (e.g., optic disc) testing techniques
(Nicolela et al., 2003). As such, a synthesis of these two data sources could
provide improvement in estimating the CPs. This would provide stronger
clinical evidence of progression as damage to the optic disc could be corrob-
orated with the VF and vice-versa (Artes and Chauhan, 2005). Finally, this
work opens up numerous avenues for future statistical research including an
extension to consider multiple CPs within a single spatial location and the
generalization of the separable multivariate spatial process to a more flexible
structure with varying dissimilarity metric parameters, αp (e.g., linear model
of coregionalization).
Acknowledgements
This work was partially supported by the National Center for Advanc-
ing Translational Science (JLW; UL1 TR001863, KL2 TR001862) and the
Research to Prevent Blindness (Department of Ophthalmology, University
25
of North Carolina-Chapel Hill). The authors thank Brigid D. Betz-Stablein
(School of Medical Sciences, University of New South Wales), William H.
Morgan (Lions Eye Institute, University of Western Australia), Philip H.
House (Lions Eye Institute, University of Western Australia), and Martin L.
Hazelton (Institute of Fundamental Sciences, Massey University) for provid-
ing the dataset from their original study for use in this analysis.
Appendix A. Implementation of the model
For a full introduction of the model, see Sections 4 and 5 of the main text.
Recall that to induce the Tobit model, we define a latent process through the
standard Tobit link, Y ∗t (s) = max {0, Yt (s)}. As mentioned in the main text,
to appropriately model the course of glaucoma progression, we will modify
the mean and variance structures to reflect the glaucoma follow-up. The
mean and variance processes are defined as follows,
µt (s) =
{
β0 (s) if 0 ≤ xt ≤ θ (si),
β0 (s) + β1 (s) {xt − θ (s)} if θ (s) ≤ xt ≤ xν ,
and
log{σt (s)} =
{
λ0 (s) if 0 ≤ xt ≤ θ (s),
λ0 (s) + λ1 (s) {xt − θ (s)} if θ (s) ≤ xt ≤ xν .
To obtain this form from the specification detailed in Section 4.1 of the main
text, set β1(s) = 0 and then recast β2(s) as β1(s). The same is done with the
variance parameters. Finally, we force the CPs from the mean and variance
to be equal.
As mentioned in Section 5, we draw samples from the joint posterior us-
ing MCMC techniques (Metropolis et al., 1953; Geman and Geman, 1984;
Gelfand and Smith, 1990). The Tobit model specification is particularly
amenable to MCMC, since the latent process has a closed form full condi-
tional distribution. To guarantee that Metropolis acceptance rates are within
an acceptable range, pilot adaptation is used (Banerjee et al., 2003). To im-
prove MCMC mixing, the VF data were scaled by 10, time was parameterized
in years, and the dissimilarity metric was scaled by 100. The MCMC sampler
is implemented in the R package spCP.
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Appendix A.1. Change point likelihood
The change point likelihood can be written for the latent Tobit process,
f
{
Yt (si)
∣∣∣β0 (si) , β1 (si) , λ0 (si) , λ1 (si) , θ (si)}
=
ν∏
t=1
m∏
i=1
[
N
(
β0 (si) , e
2λ0(si)
)]1(0≤xt≤θ(si))
× [N (β0 (si) + β1 (si) {xt − θ (si)}, e2[λ0(si)+λ1(si){xt−θ(si)}])]1(θ(si)≤xt≤xν) .
This likelihood is informative, however for computational purposes we will
write the likelihood in matrix form. The latent responses can be written more
concisely using an indicator variable. Define the event Υt (si) = 1{θ (si) ≤
xt ≤ xν}. Then,
Yt (si) = β0 (si) + β1 (si) {xt − θ (si)}Υt (si) + t (si)
= xt (si; θ)β (si) + t (si) ,
where β (si) = {β0 (si) , β1 (si)}T and xt (si; θ) = [1, {xt − θ (si)}Υt (si)].
Now, we determine the vector of latent observations at each time point,
defining Yt = {Yt (s1) , Yt (s2) , . . . , Yt (sm)}T ,
Yt = Xt (θ)β + t,
where t = {t (s1) , t (s2) , . . . , t (sm)}T , the regression coefficient vector
β =
{
β (s1)
T ,β (s2)
T , . . . ,β (sm)
T
}T
and Xt (θ) is an m×2m block diagonal
matrix with blocks entries xt (si; θ). Finally, we write the full latent process,
Y =
{
YT1 ,Y
T
1 , . . . ,Y
T
ν
}T
,
Y = X (θ)β + ,
where  =
{
T1 , 
T
2 , . . . , 
T
ν
}T
and X (θ) is an mν × 2m matrix stacking the
Xt (θ) matrices.
Having written the mean process in matrix form, we turn our attention
to the variance process. Define, σ2t = {σ2t (s1) , σ2t (s2) , . . . , σ2t (sm)}T . Then
σ2 =
{
(σ21)
T
, (σ22)
T
, . . . , (σ2ν)
T
}T
. The variance process can be written
using the same form as the mean process,
log {σ} = X(θ)λ =⇒ σ2 = exp{2X(θ)λ},
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where λ =
{
λ (s1)
T ,λ (s2)
T , . . . ,λ (sm)
T
}T
, with λ(si) = {λ0(si), λ1(si)}T .
Define the full likelihood covariance as Ω = Diag (σ2). Then, we can write
the matrix likelihood as follows,
f (Y|β,λ,θ) ∼ MVN (X (θ)β,Ω)
log {σ} = X (θ)λ,
where θ = {θ (s1) , θ (s2) , . . . , θ (sm)}T .
Having written the likelihood in a convenient matrix form, we now write
the full data likelihood which will be used to find the full conditionals. Note
that the likelihood does not include θ, but rather is parameterized to include
the generating parameters,
f (Y,β,λ,η, δ,Σ, α) ∝ f (Y|β,λ,η)
× f ({β,λ,η} |δ,Σ, α) f (δ) f (Σ) f (α) ,
where η = {η(s1), η(s2), . . . , η(sm)}T .
Appendix A.2. Full conditional distributions
1. Gibbs Step for δ :
Note that (1m ⊗ δ) = (1m ⊗ I5)δ = Zδδ. Then,
f (δ|·) ∝ f (φ|δ,Σ, α)× f (δ)
∝ exp
{
−1
2
[
{φ− Zδδβ}T
(
Q(α)⊗Σ−1) {φ− Zδδ}+ δTδ
κ2
]}
∝ exp
{
− 1
2
[
δT
{
ZTδ
(
Q(α)⊗Σ−1)Zδ + I5
κ2
}
δ
− 2δT {ZTδ Ω−1φ}
]}
∼ MVN(Eδ,Cδ),
where Cδ =
{
ZTδ (Q(α)⊗Σ−1) Zδ + I5κ2
}−1
, Eδ = Cδ
{
ZTδ Ω
−1φ
}
.
2. Gibbs Step for β :
It is not immediately obvious, but with some manipulation we can
find a closed form full conditional distribution for β. The key is that
we can find an analytical form of the distribution f (β|λ,η, δ,Σ, α).
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Recall that, C (φ) = Q (α)−1 ⊗Σ. Define, k = {1, 2} and j = {3, 4, 5}
as the indeces of the components of β in the vector of random effects
φi. The mean can be partitioned as,
1m ⊗ δ =
[
1m ⊗ δk
1m ⊗ δj
]
.
The covariance matrix can then be partitioned in block form as follows,
Σ =
[
Σkk Σkj
Σjk Σjj
]
,
so that,
Q (α)−1 ⊗Σ =
[
Q (α)−1 ⊗Σkk Q (α)−1 ⊗Σkj
Q (α)−1 ⊗Σjk Q (α)−1 ⊗Σjj
]
.
Define φij as the original φi vector, only keeping the indeces included in
j and φj =
{
φT1j,φ
T
2j, . . .φ
T
mj
}T
Using the properties of the multivariate
normal distribution we can compute the moments of the distribution
f (β|λ,η, δ,Σ, α) ∼ MVN(Ek|j,Ck|j),
Ek|j = E[β|λ,η, δ,Σ, α] = (1m ⊗ δk) +
[
Q (α)−1 ⊗Σkj
]
× [Q (α)−1 ⊗Σjj]−1 (φj − (1m ⊗ δj))
= (1m ⊗ δk) +
[
In ⊗ΣkjΣ−1jj
]
× (φj − (1m ⊗ δj)),
and
Ck|j = C(β|λ,η, δ,Σ, α) =
[
Q (α)−1 ⊗Σkk
]
− [In ⊗ΣkjΣ−1jj ] [Q (α)−1 ⊗Σjk]
=
[
Q (α)−1 ⊗Σk|j
]
,
where Σk|j =
(
Σkk −ΣkjΣ−1jj Σjk
)
. Now, we can derive the full condi-
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tional for β.
f (β|·) ∝ f
(
Y
∣∣∣β,λ,η)× f (β|λ,η, δ,Σ, α)
∝ exp
{
− 1
2
[
{Y −X (θ)β}T Ω−1 {Y −X (θ)β}
+
(
β − Ek|j
)T C−1k|j (β − Ek|j) ]
}
∝ exp
{
− 1
2
[
βT
{
X (θ)T Ω−1X (θ) + C−1k|j
}
β
− 2βT
{
X (θ)T Ω−1Y + C−1k|jEk|j
}]}
∼ MVN(Eβ,Cβ),
where the covariance is Cβ =
{
X (θ)T Ω−1X (θ) + C−1k|j
}−1
, and the
mean is Eβ = Cβ
{
X (θ)T Ω−1Y + C−1k|jEk|j
}
.
3. Metropolis Step for λ0 (si) :
Each λ0 (si), i = 1, . . . ,m, is sampled using a Metropolis step given the
following quantity that is proportional to the full conditional density,
f {λ0 (si) |·} ∝ f
(
Y
∣∣∣β,λ,η)× f (φ|δ,Σ, α)
∝
ν∏
t=1
[
N
(
β0 (si) , e
2λ0(si)
)]1−Υt(si)
× [N (β0 (si) + β1 (si) {xt − θ (si)}, e2[λ0(si)+λ1(si){xt−θ(si)}])]Υt(si)
× f (λ0|{β,λ1,η}, δ,Σ, α) ,
where f (λ0|{β,λ1,η}, δ,Σ, α) ∼ MVN
(
Ek|j,Ck|j
)
, with k = {3} and
j = {1, 2, 4, 5}. Here λj = {λj(s1), λj(s2), . . . , λj(sm)}T , j = 0, 1.
4. Metropolis Step for λ1 (si) :
Each λ1 (si), i = 1, . . . ,m, is sampled using a Metropolis step given the
following quantity that is proportional to the full conditional density,
f {λ1 (si) |·} ∝ f
(
Y
∣∣∣β,λ,η)× f (φ|δ,Σ, α)
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∝
ν∏
t=1
[
N
(
β0 (si) , e
2λ0(si)
)]1−Υt(si)
× [N (β0 (si) + β1 (si) {xt − θ (si)}, e2[λ0(si)+λ1(si){xt−θ(si)}])]Υt(si)
× f (λ1|{β,λ0,η}, δ,Σ, α) ,
where f (λ1|{β,λ0,η}, δ,Σ, α) ∼ MVN
(
Ek|j,Ck|j
)
, with k = {4} and
j = {1, 2, 3, 5}.
5. Metropolis Step for η (si) :
Each η (si), i = 1, . . . ,m, is sampled using a Metropolis step given the
following quantity that is proportional to the full conditional density,
f {η (si) |·} ∝ f
(
Y
∣∣∣β,λ,η)× f (φ|δ,Σ, α)
∝
ν∏
t=1
[
N
(
β0 (si) , e
2λ0(si)
)]1−Υt(si)
× [N (β0 (si) + β1 (si) {xt − θ (si)}, e2[λ0(si)+λ1(si){xt−θ(si)}])]Υt(si)
× f (η|{β,λ}, δ,Σ, α) ,
where f (η|{β,λ}, δ,Σ, α) ∼ MVN (Ek|j,Ck|j), with k = {5} and j =
{1, 2, 3, 4}.
6. Metropolis Step for α :
We transform α to the real line to facilitate sampling. Define a new
parameter ∆ = h(α) = log
(
α−aα
bα−α
)
, such that h−1(∆) = (bα exp{∆} +
aα)/(1 + exp{∆}) and
∣∣ ∂
∂∆
h−1(∆)
∣∣ ∝ exp{∆}/(1 + exp{∆})2. Now we
can sample from the transformed proposal distribution, ∆∗ ∼ N (∆, δ),
where δ is a tuning parameter. Then we can obtain a proposal of α,
α∗ = h−1(∆∗).
f (α|·) ∝ f (φ|δ,Σ, α)× f (α)×
∣∣∣∣ ∂∂∆h−1(∆)
∣∣∣∣ .
7. Gibbs Step for Σ :
Define Φ5×n = {β0,β1,λ0,λ1,η}T . Note that φ = vec(Φ). There-
fore, using the following properties of the Kronecker product and trace,
(BT ⊗A)vec(X) = vec(AXB) and tr(AB) = vec(A)Tvec(B) and defin-
ing M = δ1Tm, we may rewrite the MCAR prior, f(φ|δ,Σ, α), as
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follows,
∝ exp
{
−1
2
(φ− (1m ⊗ δ))T
(
Q(α)⊗Σ−1) (φ− (1m ⊗ δ))}
= exp
{
−1
2
(vec(Φ)− vec(M))T (Q(α)⊗Σ−1) (vec(Φ)− vec(M))}
= exp
{
−1
2
vec(Φ−M)T (Q(α)⊗Σ−1) vec(Φ−M)}
= exp
{
−1
2
vec(Φ−M)Tvec (Σ−1(Φ−M)Q(α))}
= exp
{
−1
2
tr
(
(Φ−M)TΣ−1(Φ−M)Q(α))}
= exp
{
−1
2
tr
(
(Φ−M)Q(α)(Φ−M)TΣ−1)}
= exp
{
−1
2
tr
(
SΦ,αΣ
−1)} ,
where SΦ,α = (Φ−M)Q(α)(Φ−M)T . Now, the full conditional for Σ
is straight forward,
f(Σ|·) ∝ f(φ|δ,Σ, α)× f(Σ)
∝ |Q(α)⊗Σ−1| 12 exp
{
−1
2
tr
(
SΦ,αΣ
−1)}
× |Σ|−(ξ+p+1)2 exp
{
−1
2
tr(ΨΣ−1)
}
∝ (|Σ−1|m|Q(α)|p) 12 exp
{
−1
2
tr
(
SΦ,αΣ
−1)}
× |Σ|−(ξ+p+1)2 exp
{
−1
2
tr(ΨΣ−1)
}
∝ |Σ−1|m2 exp
{
−1
2
tr
(
[SΦ,α + Ψ]Σ
−1)} |Σ|−(ξ+p+1)2
∝ |Σ|−m2 exp
{
−1
2
tr
(
[SΦ,α + Ψ]Σ
−1)} |Σ|−(ξ+p+1)2
∝ |Σ|−(m+ξ+p+1)2 exp
{
−1
2
tr
(
[SΦ,α + Ψ]Σ
−1)}
∼ Inverse-Wishart (m+ ξ,SΦ,α + Ψ) .
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8. Gibbs Step for Yt (si) :
The latent process Yt (si) is sampled from their full conditional distri-
bution of,
f {Yt (si) |Y ∗t (si) ,Ω} ∝ f {Y ∗t (si) |Yt (si)} × f {Yt (si) |Ω} ,
where Ω is a vector of the model parameters. Then, we know that there
are two possibilities, Y ∗t (si) = 0 or Y
∗
t (si) = Yt (si). If Y
∗
t (si) = 0,
then,
f {Y ∗t (si) |Yt (si)} = P [Y ∗t (si) = 0|Yt (si)] =
{
1 Yt (si) ≤ 0,
0 Yt (si) > 0.
Therefore, f {Yt (si) |Y ∗ (si) ,Ω} ∝ 1 {Yt (si) ≤ 0} f {Yt (si) |Ω}. Fur-
thermore, note that when Y ∗t (si) = Yt (si),
f {Yt (si) |Y ∗t (si) ,Ω} = f {Yt (si) |Yt (si) ,Ω} = Yt (si) .
Then, we see that the full conditional for the latent variable is,
f {Yt (si) |Y ∗t (si) ,Ω} ∼
{
N− (µt (si) , σ2t (si)) Y
∗
t (si) = 0,
Y ∗t (si) Y
∗
t (si) = Yt (si) .
where, N− (µ, σ2) specifies a truncated normal distribution (truncated
above by zero).
9. Repeat steps 1-8 until convergence has been achieved and an adequate
number of posterior samples have been obtained post-convergence.
Appendix B. Prediction of future change points
See Video B.1 for a map of VF progression over the course of follow-up
and into the future. The print version of this manuscript shows a still frame
that matches the right of Figure 3. The video can be found on Github:
https://github.com/berchuck/spCP.
Appendix C. Estimation of the observed change point
In Section 5 of the main text, we established the importance of estimating
the observed CPs for identifying the moment of progression. In Section 6,
we established in simulation the importance of the latent CP specification
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tDays from baseline: t =  911  ( tν  =  966 )
0.00
0.25
0.50
0.75
1.00
Pr[η(s)] < t
Video B.1: Clinical video generated from Spatial CP for the same example patient in
Figure 1 of the main text. At each location on the VF is the posterior probability of an
observed CP presented throughout follow-up and predicted one year into the future. By
presenting the CPs in video format, the present and future pattern of progression becomes
clear.
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and spatial structure for estimating both the observed and latent CPs. As a
result, it is important to understand the behavior of each modeling feature
in estimating CPs, especially at the censored spatial locations. Therefore,
we develop a second simulation study that is based on a fixed φ, so that the
CPs are fixed across all simulated datasets. The realization of φ was chosen
to produce CPs that occur across all stages of follow-up. To generate the
φ, we use the same data generating scheme as Section 6 of the main text,
with the same values of Σ and α, with δ = (25,−30, 1, 0.5, 0.5). Based on
the value of φ, 1000 datasets are simulated. In this simulation, the VF visit
times are defined as all 21 visits from Section 6 of the main text.
Each of the models were fit to the simulated datasets yielding an estimate
of the observed CPs at each VF location. In Figure C.1, the density esti-
mates of the distribution of estimated observed CPs (posterior means) are
presented for each model across the VF (excluding PLR). Furthermore, the
true observed CP is presented as a vertical black dotted line and the thresh-
old sensitivity values for an example simulated dataset are presented as gray
dots. This figure provides important information regarding the introduced
model. First, in VF locations where the true CP is near the middle of the
monitoring period (i.e., easier to identify), Spatial CP has minimal bias and
has the narrowest bounds (representative of the variability in the posterior
mean estimates). In these settings, the other models generally have small
bias, however the density estimates are much wider.
In locations where the true CP is near or beyond the beginning or end
of the monitoring period, Spatial CP is clearly superior. The two models
that have no latent CP process are incapable of approaching the edges of
the follow-up times, with apparent bias. Non-spatial CP (L) provides an
improvement, allowing the density estimate to approach the bounds. How-
ever, it is important to note that this appears to be a trade-off with wider
densities in locations with a true CP in the middle of follow-up. The only
model that is capable of producing acceptable CP estimation in the middle
and bounds of follow-up is Spatial CP. Interestingly, at certain VF locations
at the boundaries, Spatial CP is capable of producing a point mass, meaning
all posterior means are the same.
To formalize the results seen in Figure C.1, summary diagnostics are
presented in Table C.1. The results for Non-spatial CP (D) are excluded,
since the results are not directly comparable. The results in Table C.1 confirm
the trends observed in Figure C.1 as the bias and MSE are improved with the
introduction of a latent process and then spatial structure. Spatial CP has
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Figure C.1: Simulation study comparing the performance of Spatial CP and non-spatial
CP models in estimating the CPs across the VF. The true value of the CP is presented as a
dotted black line and the threshold sensitivity values for an example simulated dataset are
presented as gray dots. The posterior mean estimates of the CPs across all 1000 datasets
for Spatial CP, Non-spatial CP (D), Non-spatial CP (C), and Non-spatial CP (L) are
presented as density estimates in red, blue, green, and purple lines, respectively.
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Table C.1: Summary diagnostics for estimation of the observed CPs in the simulation
detailed in Web Appendix C. The diagnostics included are bias, MSE, and EC (95%
nominal) and are presented for each of the models that are capable of estimating the
continuous observed CP. Standard errors (SE) correspond to the variation across all VF
locations and simulations. Each reported estimate is based on 1000 simulated datasets.
Metric Model Estimate (SE)
Bias
Non-spatial CP (C) 0.147 (0.171)
Non-spatial CP (L) 0.058 (0.123)
Spatial CP -0.001 (0.008)
MSE
Non-spatial CP (C) 0.102 (0.065)
Non-spatial CP (L) 0.083 (0.087)
Spatial CP 0.002 (0.002)
EC
Non-spatial CP (C) 0.33 (0.461)
Non-spatial CP (L) 0.94 (0.146)
Spatial CP 0.99 (0.018)
superior bias and MSE, -0.001 and 0.002, respectively, and has the smallest
standard errors, indicating less variability in estimation across the simulated
datasets. The EC is only acceptable with the inclusion of the latent CP
process. Non-spatial CP (C) has an EC of 0.33, which is clearly a result of
all of the true CPs near the bounds. Spatial CP slightly overestimates the
nominal coverage, which corresponds to the simulation from the main text
and makes sense since the observed CP is a censored parameter. Overall,
this additional simulation provides a closer look into the estimation of the
observed CP, demonstrating the behavior of each model at various locations
over follow-up. These results again illuminate the importance of Spatial
CP for estimating the observed CP, especially in models with CPs near the
bounds of follow-up, which are commonly the interesting patients.
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